Related references
Note: Only part of the references are listed.Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden
Jianguang Ji et al.
LANCET ONCOLOGY (2012)
A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma
Wei-Yi Cheng et al.
PLOS ONE (2012)
The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
Suzanne A. Eccles
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease
Jessica M. Simpson et al.
NEUROBIOLOGY OF DISEASE (2011)
Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1
Hoon Kim et al.
BMC MEDICAL GENOMICS (2010)
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
Carlos A. Castaneda et al.
CANCER AND METASTASIS REVIEWS (2010)
Distinct Biological Roles for the Akt Family in Mammary Tumor Progression
Rachelle L. Dillon et al.
CANCER RESEARCH (2010)
Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression
Mahmoud A. Pouladi et al.
HUMAN MOLECULAR GENETICS (2010)
Huntingtin Is Required for Mitotic Spindle Orientation and Mammalian Neurogenesis
Juliette D. Godin et al.
NEURON (2010)
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Chiara Zuccato et al.
PHYSIOLOGICAL REVIEWS (2010)
pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking
Raul Pardo et al.
MOLECULAR BRAIN (2010)
Huntington's disease: The current state of research with peripheral tissues
Jenny Sassone et al.
EXPERIMENTAL NEUROLOGY (2009)
Beyond the brain: widespread pathology in Huntington's disease
Jorien M. M. van der Burg et al.
LANCET NEUROLOGY (2009)
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled et al.
NEUROBIOLOGY OF DISEASE (2009)
Neuroendocrine Disturbances in Huntington's Disease
Nadine Saleh et al.
PLOS ONE (2009)
Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
Kirstine Roepstorff et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons
Diana Zala et al.
HUMAN MOLECULAR GENETICS (2008)
Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent
Nina Marie Pedersen et al.
MOLECULAR CANCER RESEARCH (2008)
Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease
Caroline L. Benn et al.
MOLECULAR NEURODEGENERATION (2008)
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Amanda L. Lumsden et al.
HUMAN MOLECULAR GENETICS (2007)
Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression
Fanny Mochel et al.
PLOS ONE (2007)
Huntingtin facilitates dynein/dynactin-mediated vesicle transport
Juliane P. Caviston et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Huntingtin interacting proteins are genetic modifiers of neurodegeneration
Linda S. Kaltenbach et al.
PLOS GENETICS (2007)
Establishment of human tumor xenografts in immunodeficient mice
Christopher L. Morton et al.
NATURE PROTOCOLS (2007)
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: Comparison of success rate and cell line features
Virginie Dangles-Marie et al.
CANCER RESEARCH (2007)
Huntington's disease:: from huntingtin function and dysfunction to therapeutic strategies
M. Borrell-Pages et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors
M. D. Landis et al.
ONCOGENE (2006)
Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421
R Pardo et al.
JOURNAL OF NEUROSCIENCE (2006)
Huntingtin associates with acidic phospholipids at the plasma membrane
KB Kegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo -: art. no. 17
JM Woda et al.
BMC DEVELOPMENTAL BIOLOGY (2005)
Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo
SC Warby et al.
HUMAN MOLECULAR GENETICS (2005)
Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila
JC Liévens et al.
HUMAN MOLECULAR GENETICS (2005)
Akt is altered in an animal model of Huntington's disease and in patients
E Colin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Huntingtin-protein interactions and the pathogenesis of Huntington's disease|
SH Li et al.
TRENDS IN GENETICS (2004)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin
CD Austin et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells
S Gines et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
C Zuccato et al.
NATURE GENETICS (2003)
The hunt for huntingtin function: interaction partners tell many different stories
P Harjes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt
S Humbert et al.
DEVELOPMENTAL CELL (2002)
Expression of full-length polyglutamine-expanded huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells
C Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription
KB Kegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway
A Brunet et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Huntingtin is required for normal hematopoiesis
M Metzler et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
